Latest Industry Insights

Industry Insight
Advancing Antibody Innovation Through Discovery, Customization and Sustainability
In this interview, Technology Networks spoke with Dr. Sophie Mayle, Dr. Paul Royle and Dr. John Cardone from Bio-Rad's custom antibody services team, to learn more about the developments and future directions within antibody innovation.

Industry Insight
Why Good Science Is Key to Good Technology
In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.

Industry Insight
Advancing Protein Prototyping Through Rapid and Efficient Systems
In this interview, we learn more about Nuclera's eProtein Discovery™ system, cutting protein production to 48 hours, solving solubility challenges and accelerating R&D with a "fail fast, succeed faster" strategy.

Industry Insight
Organization-Level Support for Lab Sustainability: A Perspective From the Field
Levi Rogers reviews organizational-level support for lab sustainability, including developing organizational sustainability commitments, employee reward programs and cross-organizational partnerships.

Industry Insight
The Rise of Cell and Gene Therapies in Treating Complex Diseases
Cell and gene therapies are revolutionizing medicine. Looking to 2025, advancements in allogeneic therapies, streamlined autologous processes and broader applications promise increased accessibility and innovation in treating complex diseases.

Industry Insight
Biobanking Quality Management Systems and Best Practices
As we discussed in our last post, the Role of Biobanking in Protecting Sample Chain of Custody, biobanks serve as biospecimen libraries as well as sample data, validation, and reference sources for both research and clinical labs.

Industry Insight
Role of Biobanking in Protecting Sample Chain of Custody
This blog series will examine current and foreseen challenges for biobanks, as well as the systems and practices that mitigate these challenges.

Industry Insight
Could AI Unlock Zero-Cost Gene Therapy Delivery?
Dr. Eric Kelsic, CEO and co-founder of Dyno Therapeutics, explains how AI could reduce the cost of gene therapy delivery to $0.

Industry Insight
A Glimpse Into the Technologies Behind Upcoming UK Biotech Start-Ups
The Discovery Spark program aims to help upcoming biotechnology and healthcare companies grow. In this article, we take a closer look at some of the innovative technologies of this year's Discovery Spark cohort.

Industry Insight
Transforming Bioprocessing With Digital Innovation
In this interview, Simon Wieninger discusses the critical role digital tools play in improving bioprocessing efficiency, how cloud technologies and data harmonization can overcome key challenges and the importance of maintaining robust data security.
Advertisement